[What is reliable in therapy of acute cerebral ischemia?].
Hennerici
M G
MG
Neurologische Universitätsklinik, Klinikum Mannheim, Universität Heidelberg.
Schwartz
A
A
D001921:Brain / Q000503:physiopathology; D002545:Brain Ischemia / Q000503:physiopathology / Q000628:therapy*; D002544:Cerebral Infarction / Q000503:physiopathology / Q000628:therapy*; D013181:Cortical Spreading Depression / Q000187:drug effects / Q000502:physiology; D004630:Emergencies; D004734:Energy Metabolism / Q000502:physiology; D018691:Excitatory Amino Acid Antagonists; D005971:Glutamates / Q000502:physiology; D018698:Glutamic Acid; D006801:Humans; D010101:Oxygen Consumption / Q000502:physiology; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors / Q000502:physiology
D018691:Excitatory Amino Acid Antagonists; D005971:Glutamates; D016194:Receptors, N-Methyl-D-Aspartate; D018698:Glutamic Acid
Was ist gesichert in der Therapie der akuten Hirnischämie?